首页> 中文期刊> 《临床医药实践》 >痰热清注射液在慢性阻塞性肺疾病急性加重期治疗中的疗效评价

痰热清注射液在慢性阻塞性肺疾病急性加重期治疗中的疗效评价

         

摘要

目的:观察静脉滴注痰热清注射液治疗慢性阻塞性肺疾病急性加重期的效果。方法:将62例慢性阻塞性肺疾病急性加重期患者按数字表法分为治疗组(32例)和对照组(30例)。对照组采用常规治疗方法,用多索茶碱平喘,甲强龙抗炎,依从经验性或痰液病原学检查结果进行抗感染治疗及布地奈德、可必特雾化吸入。治疗组在常规治疗基础上加用痰热清注射液静脉滴注,比较两组病例病情好转或临床缓解情况。结果:治疗组患者住院天数、静脉应用抗生素天数、肺内哮鸣音明显减少或消失时间、C反应蛋白、中性粒细胞计数、血气分析等方面与对照组比较差异有统计学意义。结论:加用痰热清注射液静脉滴注,患者住院天数明显减少,同时肺部感染较快得到良好控制,明显改善患者喘憋症状,疗效满意,极大地减轻患者痛苦。%Objective:To observe the clinical effect of intravenous infusion of tanreqing injection,and to explore its thera-peutic effect in acute exacerbation of chronic obstructive pulmonary disease. Methods:All 62 cases of acute exacerbation of chronic obstructive pulmonary disease,was divided into two groups,32 patients in the treatment group,30 cases in the control group. Control group was treated by conventional methods,doxofylline wheezing,methylprednisolone anti-inflammatory,com-pliance with empirical or sputum pathogen examination results of anti-infective therapy and budesonide,may be special inha-lation. The treatment group was given intravenous infusion of Tanreqing injection on the basis of routine treatment,and the con-dition of the two groups was improved and the clinical remission was compared. Results:There was significient difference be-tween two groups in the number of days of hospitalization,the days of intravenous antibiotics,the number of days of pulmonary wheezing decreased or disappeared,C-reactive protein,neutrophil count,blood gas analysis. Conclusion:The patient's hospi-talization time was significantly reduced,while the pulmonary infection was better controlled quickly,significantly improved in patients with wheezing symptoms,clinical efficacy is satisfactory,greatly reduce the pain of patients.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号